chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had a rash; my arm legs and chest were itchy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 26Aug2021 (Batch/Lot number: unknown) at the age of 27 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: RASH (non-serious) with onset 26Aug2021, outcome "unknown", described as "I had a rash"; PRURITUS (non-serious) with onset 26Aug2021, outcome "unknown", described as "my arm legs and chest were itchy". Therapeutic measures were not taken as a result of rash, pruritus.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. Patient was not tested for covid post vaccination.  Follow-up (07Oct2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Initial report received from a health care provider on 22 September 2008.  A 44-year-old male patient had received doses of MENACTRA, ADACEL, YF VAX, IPOL and TWINRIX (manufacturer GlaxoSmithKline) on 05 September 2008 (lot numbers were unknown and routes/sites of administration were not reported for all vaccines).  On 21 September 2008, the patient called the vaccine clinic to cancel his next appointment, stating that he was hospitalized with spinal meningitis.  Patient outcome was unknown.  No additional details were provided.  10/24/08 Reviewed hospital medical records of 9/18-9/24/2008. FINAL DX: viral meningitis Records reveal patient experienced recurrent left eye conjunctivitis, generalized body aches, HA w/photophobia, fever, chills, nausea.  Patient's child w/URI.  Has frequent foreign travel for work.  Exam revealed unequal pupils.  Admitted to ICU & tx w/steroids, IV antibiotics & antivirals.  Neuro & ID consults done.
Patient said arm started to itch...after looking at arm, look red around the site of injection.
Left cervical lymph node; raised/hard. Left deltoid slightly edematous with erythema. Patient also complained of sore throat. Treatment: Ibuprofen 600mg T PO TID for 10 days. Erythromycin 500mg T PO TID for 10 days.
Pt recvd 3 doses of Engerix-B vax & 6NOV90, 4DEC90, & 10MAY91 & on 29SEP91 it was determined that pts titer was neg p/3 doses of Engerix-B;
Pt. developed rash "hives" on (L) arm + itching and rash on (R) flank "hives" 1 day post vaccination. Symptoms resolved in 48 hrs.
Rash and/or hives began in a small area initially on right wrist moving over to include underside of wrist and arm to inside elbow area. Over approximately the next week several other areas developed hives - left arm- wrist to inside elbow , chest, neck, jaw, slight area on face and  a 2" round spot on top of right foot. Extremely itchy! Started using Benadryl Gel and Benadryl tablets for itching,  didn't really seem to help much. Dr prescribed a topical cream with a steroid in it to reduce itching. No noticeable change. Also switched from Benadryl to Zyrtec tabs. Nothing seems to improve itching - can't sleep. Rash is currently dissipating slowly - no new areas for 1 week.
side effects of sore arm; mild itching; This is a spontaneous report from a contactable consumer. A 61-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on 11Jan2021 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history was not reported. There were no concomitant medications. On an unspecified date, the patient reported side effects of sore arm and mild itching and she stated they were very mild and lasted about 72 hours. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
A non-serious spontaneous report of inadvertently given half dose of H1N1 LAIV was received from a registered nurse/health professional concerning a 36-year-old female. The patient's medical history and concomitant medications was not reported. On 27-Oct-2009, the patient was inadvertently given half dose (0.1 ml) of H1N1, Intranasal. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved.
Pelvic pain, menstrual cycle began 2 weeks after 2nd injection and continues to now come every 2 weeks.  It should be clarified that I have zero history of irregular cycles.  Initially, went to clinic when I could not get in with my Dr.  they treated me for BV, YI though I had no symptoms associated with either of those infections.  2 weeks later symptoms again, I got an appointment with my regular Dr who advised the pelvic pain was from the vaccine and to give it 3-4 months to calm down my cycle.  In the meantime, the results from the clinic came back with an abnormal pap  with HPV.  It is my belief that the vaccine triggered HPV.   I've been super healthy and never have issues.
Developed some hives and generalized itchy feeling, feeling of agitation.  Took Benedryl 25 mg P.O., , hives and itching gone by morning.
pt recv vax & approx 5hr later pt devel extreme fatigue, pounding h/a, chills, facial flushing, large red blotches on cheeks, pricking feeling from head sown through lower extreme, intermittent numbness & tingling,diff concentrating;
After receiving 3rd dose of vaccine in the morning, individual described it as if head was burning overnight with the back of head (near neck) still painful in the morning.; After receiving 3rd dose of vaccine in the morning, individual described it as if head was burning overnight with the back of head (near neck) still painful in the morning.; This is a spontaneous report from a contactable reporter (consumer or other non-HCP).   An adult male patient received bnt162b2 (BNT162B2), administration date 09Feb2022 (Lot number: unknown) as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: unknown), for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot Number: unknown), for COVID-19 immunisation.  The following information was reported: BURNING SENSATION (non-serious), HEADACHE (non-serious) all with onset 09Feb2022, outcome "unknown", and all described as "After receiving 3rd dose of vaccine in the morning, individual described it as if head was burning overnight with the back of head (near neck) still painful in the morning.".   Additional information: Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. It was unknown if the patient received treatment for the adverse events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
T102, rash on front, back, neck, face, legs, feet, buttocks, ears;MD dx measles pt also exp vomiting, diarrhea, low grade temp;
Booster given (pt did not tell us had reaction in past). 1-2 hrs later arm became red, over next several days hard, warm, painful. 3x2" in size. Only report because we had four other that we reported with same batch within 2 wks.
This spontaneous report was received from a doctor of pharmacy concerning a patient of unknown age and gender. It was reported that doses of M-M-R II (lot number, expiry date, dose and route unspecified) were exposed to 80 degrees Fahrenheit (F) for one day and above 46 degrees Fahrenheit (F) for unspecified amounts of time from 01-OCT-2013 to 31-OCT-2013 which was not supported. It was unsure if any doses were administered. No concomitant therapy was reported. No adverse effects were reported. This is one of the several reports from the same source. Additional information has been requested.
within a few minutes of injection , patient was not feeling well, was sweating and could not stand . We sat him down, gave water, called EMS . Patient came around within a few minutes , emergency crew checked him but he refused additional medical care . Patient left after about 25 minutes and they said they felt fine
Patient says she experienced nausea, an episode of vomiting, soreness in her arm, "flu-like" symptoms, tired, sore neck.
Pain in upper arm and shoulder. Can't lift my arm all the way. Still having pain one month after the shot.
Severe muscle aches and pain.  Using Tylenol to alleviate, but has not completely stopped symptoms
Patient was given the hepatitis A vaccine by RN in the left deltoid.  After given the vaccine and sitting for approximatly 5 minutes aferwards she indicated she felt fine and stood against a wall and was talking with a coworker.  Patient lost consciousness about two minutes later and slid down the wall and employee heard and observed her bumping her head lightly.  Patient lay on her right side while tended to by employee and nurse.  She had some jerking body movements which lasted a few seconds.  Regained consciousness in about 5 seconds.  Employee asked her where she was, her name and what the last thing she remembered was.   fully alert.  Nurse took vital signs while patient sat against the wall; pulse 56, blood pressure 102/66, temp 98.6 F, O2 sats 98%.  patient sat under observation for 30 minutes, drank some water, reported feeling fine and was escorted out of the programs room. Follow up done by health services per their protocol.Patient answered all of these questions appropriately and was
patient had a red rash on face the morning after vaccination.  unclear if related. did not seek treatment as it was not painful. monitoring for any wrosening of the rash.
Myalgia & NauseaVomiting Narrative: Fatigue, nausea with abdominal pain and chills
pt recv vax 17OCT96 & same day pt passed out p/blood rushed to head, ear were ringing & had heart palpitation;19OCT96 devel laryngitis extreme weakness, shakes for 2 days;NOV96 exp panic attacks;dx mild depression;17OCT96 sweating;
Patient had vaccination and remained in pharmacy area.  He came up to the pharmacy window as his wife is a pharmacy technician about to clock out and patient collapsed and went down to the ground after fainting.  Patient was clammy, sweating, and had visual disturbances.  I laid patient down and put feet up in the air.  Gave two ice packs and a ginger ale.  Gave a dose of benadryl as a precautionary measure.  Patient remained supine position for 15 minutes or so at which time we helped to a sitting position and eventually standing position.  Patient felt much better at this time, was no longer clammy and sweating, and had regained some color in his face.  Patient was instructed not to drive home - his wife drove.
Very sore injection site, flu like symptoms, after 1 1/2 months, I had blurry vision in my right eye. Was admitted hospital, had a 5 day stay. Had artery bx on both sides of my head, 2 MRI's, pet scan, ct scan, spinal tap, heart monitoring, all negative for blood clot, cancer and giant cell arteritis. My vision is still compromised. But improving. Diagnosed with ischemic optic neuropathy.
passed out; Dizzy; fell; This is a spontaneous report from a contactable consumer (patient). A 41-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 27May2021 at 18:30 (Batch/Lot Number: EW0180) (at the age of 41-years-old) as dose 2, single for COVID-19 immunisation. Medical history included minor asthma and known allergies to some fruits and vegetables. The patient did not have COVID prior to vaccination. Concomitant medications included levothyroxine, fish oil and unspecified multivitamins; all taken for an unspecified indication, start and stop date were not reported. The patient was previously administered with first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EW0167) via unspecified route of administration, administered in the left arm on 01May2021 (at the age of 41-years-old) for COVID-19 immunisation. On 28May2021 at 09:00, the patient felt dizzy, passed out then fell. The patient was not given any treatment for the events. The patient was not tested for COVID post vaccination. Outcome of events was recovered on an unspecified date.
MACULAR DEGENERATION; CATARACT IN RIGHT EYE; SORENESS LEFT ARM; This spontaneous report received from a patient concerned a 73 year old male of unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient's concurrent conditions included non-alcohol user, and other pre-existing medical conditions included no drugs abuse, no heart condition, no lung condition and had good vitals. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: 05-AUG-2021) dose was not reported with frequency of 1 total dose administered at left arm on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, since vaccination, patient had experienced soreness in the arm (difficulty to put his left arm behind his back) and his vision began to slowly degrade. On an unspecified date, two weeks ago, his vision became so blurry that he literally couldn't see, patient was very concerned that he might become completely blind. Patient vision was degrading and the blurriness was worsening. Patient still experienced pain in his left arm. On 30-JUN-2021, patient went to the eye doctor, they examined him and concluded to a macular degeneration (prescribed high volume of vitamin C (ascorbic acid) and A (colecalciferol/retinol), caller was unsure if the treatment was helping or not) and to a cataract in his right eye. Physician also said that no corrective lenses were going to fix it and that patient might need Lasix surgery. Severity of eye on a scale of 20 (perfect vision) and 0 (blind) showed before left eye: 19/20 and right eye: 17/20 and now left eye : 4-5-6/20 and right eye : 3/20. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from soreness left arm, macular degeneration/vision became so blurry that he literally couldn't see, and cataract in right eye. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20210728718-covid-19 vaccine ad26.cov2.s-Macular degeneration,Cataract right eye.This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Chills; body aches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and PAIN (body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced CHILLS (Chills) and PAIN (body aches). At the time of the report, CHILLS (Chills) and PAIN (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Patient had symptoms of COVID January 14th but was never tested. He received his 2nd dose of vaccine on January 29th. Patient had no issued until 2/9 when he collapsed in gym class while running and was brought to the emergency room. He went into flash pulmonary edema and then coded with low cardiac function seen on bedside ECHO. He was placed on ECMO and started on epinephrine and milrinone drips. He remained on ECMO for 7 days when he was decannulated. He went to a cardiac catheter procedure which showed left main coronary artery narrowing and cardiac MRI showed possible transmural infarct .  He was transferred to another hospital and is still inpatient pending possible LVAD or heart transplant.
Shortness of breath/difficulty breathing; Throat swelling; Arm soreness; This is a spontaneous report from a contactable nurse, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm (also reported as left deltoid) on 08Nov2021 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included depression. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included bupropion (MANUFACTURER UNKNOWN), for an unknown indication from an unknown date and unknown if ongoing. The patient previously received sertraline hydrochloride (ZOLOFT) and experienced drug allergy. On 08Nov2021 at 17:30, the patient experienced shortness of breath, difficulty breathing, throat swelling and arm soreness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with cetirizine hydrochloride (ZYRTEC) and then diphenhydramine hydrochloride (BENADRYL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shortness of breath/difficulty breathing, throat swelling and arm soreness were resolving at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
yellow bruising on arm; welt; some heat; itching; dry mouth; unquenchable thirst; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (dry mouth), THIRST (unquenchable thirst), CONTUSION (yellow bruising on arm), URTICARIA (welt) and VACCINATION SITE WARMTH (some heat) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced DRY MOUTH (dry mouth) and THIRST (unquenchable thirst). On 23-Feb-2021, the patient experienced URTICARIA (welt), VACCINATION SITE WARMTH (some heat) and PRURITUS (itching). On an unknown date, the patient experienced CONTUSION (yellow bruising on arm). On 16-Feb-2021, DRY MOUTH (dry mouth) and THIRST (unquenchable thirst) had resolved. At the time of the report, CONTUSION (yellow bruising on arm), URTICARIA (welt), VACCINATION SITE WARMTH (some heat) and PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
At 16:00, the pt displayed symptoms of itchy throat, watery eyes, lethargic, PR-110, R-20, BP-140/80 and complained of mid-sternal chest pain and wheezing. O2 via mask was given at 3L/minute IV, NS, Epinephrine .3mg SC. EMS called and responded. Pt taken to ER; alert and responsive with decreased chest pain.
Began with symptoms of sore throat, loss of taste  05/18/2021-  Developed facial drooping and numbness- diagnosed with Bells Palsy 5/21/2021.
Episodic, rapid thumping sound in left ear.  Much more rapid than heartbeat.  Some sort of tinnitus.  Comes and goes.
Developed shingles on her right abdomen; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Developed shingles on her right abdomen) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced HERPES ZOSTER (Developed shingles on her right abdomen). At the time of the report, HERPES ZOSTER (Developed shingles on her right abdomen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Varicella vaccine administered on 2/18/16, returned to Employee Health on Monday, 2/22/16 stating rash on (R) upper arm (weeping, small pinhead sized vesicles) and (R) forearm - raised red rash - no vesicles - and (L) wrist - pinpoint flat healing spots - no vesicles.
This spontaneous report as received from a Certified Medical Assistant refers to an unspecified number patients of unknown age and gender. The reporter stated that doses of vaccines LIQUID PEDVAXHIB (dose, route and lot# not reported) that were exposed to a supported temperature excursion that occurred on 29-JUL-2014 had been administered to unspecified patients on unspecified dates. The reporter reported that she had not been informed of any adverse effects. It was unknown if the patients sought medical attention or not. At the time of report, the status of patients was unknown. This is one of the several reports received from the same reporter. Additional information has been requested.
Currently experience redness, swelling, and hot area around the injection site. Treating with ibuprofen and ice.
extreme itching on my neck; extreme itching on my neck; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EM9809), via an unspecified route of administration on 06Mar2021 (at the age of 34-year-old), dose 1, single for COVID-19 immunisation. Medical history included depression, asthma, irritable bowel syndrome (IBS), gastrooesophageal reflux disease (GERD), polycystic ovarian syndrome (PCOS), extreme itching on neck (this was how she discovered that she was allergic to other medications) and had allergies to kiwi, pineapple, oranges, bananas, latex, dogs, cats. Concomitant medications included prescribed medications, multi-vitamins, and birth control medications. The patient previously took acetaminophen; ondansetron (ZOFRAN); hydromorphone hydrochloride (DILAUDID); hydrocodone bitartrate paracetamol (NORCO) and had allergy to these medications. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior. The patient was not pregnant at the time of vaccination. The vaccine was administered at hospital. On an unspecified date in Mar2021, the patient had extreme itching on her neck. The patient stated that she became concerned because this was how she discovered that she was allergic to other medications. The patient spoke with the emergency room (ER) and then had a telehealth visit with her primary doctor. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was unknown.  No follow-up attempts are possible; No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021347541 same reporter/patient/product, different dose and similar events
Received Hep B booster at approx. 2 p.m. on 2/25/03. By 12:00 p.m  she had cough. By evening of 2/26/03 she also spiked fever of 102. On a.m. of 2/27/03 fever gone but chest tight from cough. Sent to clinic and had 3 neb. treatments and rx for inhaler.  Symptoms resolved with no sequelae at time of this report.